US-backed vaccine trial on babies canceled after international outcry
Summary
Authorities in Guinea-Bissau have officially canceled a planned clinical trial involving newborns. The research, which was backed by the United States and led by Danish scientists, aimed to examine potential issues associated with the standard newborn hepatitis B vaccine.
Government officials in Guinea-Bissau have formally rejected a clinical trial that would be run by Danish researchers and funded by the US to look for alleged nonspecific harms from the newborn dose of the hepatitis B vaccine. The vaccine dose is currently recommended globally for all newborns and has been used safely and effectively for decades. In an email to…
Source: Read the full story at Ars Technica - All content
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.